Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Approval marks the third indication for the IL-23 inhibitor in adults → Read More
Ustekinumab, adalimumab both effective in SEAVUE trial, with no difference in remissions → Read More
Registry-based study finds association with antibiotics that target gastrointestinal pathogens → Read More
Findings from Nurses' Health Study II lend support to latest recommendations → Read More
Oral trientine tetrahydrochloride gains indication for adults who are tolerant to penicillamine → Read More
Danish study finds no association between mRNA vaccines and appendicitis → Read More
Agency eyes adenovirus infection as possible cause behind recently reported cases → Read More
Clinical risk factors were not as important, study finds → Read More
Study argues liver, kidney transplantation is a viable option for patients with HIV → Read More
Real-world dataset supports need for extra doses in immunocompromised groups → Read More
First interchangeable biosimilar approved, biologics go head-to-head → Read More
Head-to-head trial pits medium-weight polypropylene meshes against heavy-weight mesh → Read More
Historical data among adults ages 45 to 50 show ominous trends → Read More
Gaps in PrEP use more likely among minority groups, young people, and those with SUD → Read More
Adding exposure to internet-based cognitive behavioral therapy could cut costs in the long run → Read More